Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors. Wang LX, Quach HT, Moodabigil NV, Davis EJ, et al. Cancer 2020;126:322-328.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang LX, Quach HT, Moodabigil NV, Davis EJ, et al. Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors. Cancer 2020;126:322-328.
PMID: 31580492